CHEMVET PHARMA ApS: Financial statements 2022
CVR: 20386908
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CHEMVET PHARMA ApS (CVR 20386908) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 251,293 and a net result of DKK -311,604 compared with DKK -476,868 the year before. That is a decrease of 20.7% compared with the year before. Equity in the 2022 report amounted to DKK 1,777,573. The solvency ratio was 76.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 251,293
- Profit/Loss
- DKK -311,604
- Equity
- DKK 1,777,573
- Total Assets
- DKK 2,333,562
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 251K | -312K | 1.8M | 2 |
| 2021 | - | 317K | -477K | 2.1M | 2 |
| 2020 | - | 712K | 14K | 2.6M | 2 |
| 2019 | - | 742K | 2K | 2.6M | 2 |
| 2018 | - | 757K | 1K | 2.5M | 2 |
Official annual report
Keep an eye on CHEMVET PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CHEMVET PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 316,753, and the net result was DKK -476,868.
About CHEMVET PHARMA ApS
CHEMVET PHARMA ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 1997. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named ApS KBIL 9 NR. 2027. The management consists of Frank Arvé Christensen. The board consists of Sarah Arvé (chair), Frank Arvé Christensen and Maria Arvé Brostrøm. The company is owned by Frank Arvé Christensen, Sarah Arvé and Maria Arvé Brostrøm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,700,759 and a net result of DKK 970,939 compared with DKK 807,613 the year before. Equity in the 2025 report amounted to DKK 3,822,846.